产品名称 | NebuSelect™ Recombinant Biotinylated Human TRAIL R4/TNFRSF10D, Avi-His-tag |
---|---|
目录号 | NBL-241986 |
别名 | TRAIL R4/TNFRSF10D; CD264; RSF10D; TRAILR4; DCR2; TRUNDD; TNFRSF10D |
外观 | see COA |
分子量 | Ala56-His211 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9UBN6 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241986-100ug | 100ug | Inquire | Inquire | |
NBL-241986-1mg | 1mg | Inquire | Inquire | |
NBL-241986-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human TRAIL R4/TNFRSF10D, Avi-His-tag
Catalog#:
NBL-241986
Description:
NebuSelect™ Recombinant Biotinylated Human TRAIL R4/TNFRSF10D, Avi-His-tag(Cat#NBL-241986) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Ala56-His211.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 19.4 kDa. Due to glycosylation, the protein migrates to 38-50 kDa based on Bis-Tris PAGE result.
Target Name:
TRAIL R4/TNFRSF10D; CD264; RSF10D; TRAILR4; DCR2; TRUNDD; TNFRSF10D
Target Information:
TNF-related apoptosis inducing ligand (TRAIL) is a potential antitumor protein known for its ability to selectively eliminate various types of tumor cells without exerting toxic effects in normal cells and tissues. TRAIL-R2/DR5 as well as TRAIL-R3/DcR1 and TRAIL-R4/DcR2 were significantly higher expressed in advanced tumour stages.
Amino Acid Sequence:
Ala56-His211
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.